Guidance for market authorization requirements for COVID-19 drugs: Quality and manufacturing requirements - Guidance for market authorization requirements for COVID-19 drugs: Quality and manufacturing requirements
There are no views created for this resource yet.
Additional Information
| Created | July 28, 2022 |
|---|---|
| Format | HTML |